Robotic Neurorehabilitation in Patients With Ataxia (NCT07733687) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Robotic Neurorehabilitation in Patients With Ataxia
Hungary100 participantsStarted 2026-06-02
Plain-language summary
This interventional study evaluates the effectiveness of robot-assisted neurorehabilitation in patients with ataxia. Participants will receive a structured robotic neurorehabilitation treatment program, and changes in motor function, coordination, balance, gait, and functional performance will be assessed using clinical outcome measures before and after the intervention.
Who can participate
Age range
18 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Adults diagnosed with ataxia
* Age 18 years or older
* Ability to participate in a robot-assisted neurorehabilitation program
* Stable clinical condition allowing participation in rehabilitation treatment
* Ability to understand and follow study instructions
* Ability to complete the planned clinical and functional assessments
* Written informed consent provided by the participant
Exclusion Criteria:
Severe cognitive impairment preventing cooperation with the intervention or assessments
* Severe musculoskeletal or neurological condition that prevents safe participation in robot-assisted rehabilitation
* Unstable cardiovascular, respiratory, or other medical condition contraindicating rehabilitation treatment
* Severe pain or orthopedic limitation preventing participation in the rehabilitation program
* Severe visual or vestibular impairment that would interfere with study assessments
* Acute medical condition or acute neurological deterioration at the time of enrollment
* Participation in another interventional clinical study that could affect the study outcomes
* Pregnancy, if participation is considered unsafe by the investigator
* Any condition judged by the investigator to make participation unsafe or unsuitable
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
SARA (Scale for the Assessment and Rating of Ataxia)